ARCHIVES

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

In Brief: Angel Bradley To Head NCAB Subcommittee UCLA, USC Join In CCRU Grant Application

September 3, 1982

Has To Plan International Meeting On Threat If DNA Biohazards

September 13, 1974

NCI Appropriations, Authorization Bills Passed By House

September 5, 1980

MIT Radiation Poisoning Was Deliberate, NRC Investigation Finds

December 15, 1995

NCI And SPORE PIs Discussing Potential Changes To Grant Program Guidelines.

September 19, 2008